CVS Health (CVS) Tops Q2 EPS by 10c; cuts profit guidance

CVS Health (NYSE: CVS) reported Q2 EPS of $1.83, $0.10 better than the analyst estimate of $1.73. Revenue for the quarter came in at $91.2 billion versus the consensus estimate of $91.43 billion.

GUIDANCE:

CVS Health sees FY2024 EPS of $6.40-$6.65, versus the consensus of $6.97.

For earnings history and earnings-related data on CVS Health (CVS) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Meta Platforms (META) call put ratio 1.7 calls to 1 put
• Carnival Corp. (CCL) call put ratio 1.2 calls to 1 put into quarter results